Incannex announces participation at the h.c. wainwright 4th annual neuropsychiatry virtual conference june 26, 2023

Melbourne, australia, june 23, 2023 (globe newswire) -- incannex healthcare limited (nasdaq: ixhl) (asx: ihl), (‘incannex' or the ‘company') a pharmaceutical company developing medicinal cannabinoid pharmaceutical products and psychedelic therapies for unmet medical needs, is pleased to announce that it will be featured as a presenting company at the h.c. wainwright 4th annual neuropsychiatry virtual conference. the conference is being held virtually on september 26, 2023.
IXHL Ratings Summary
IXHL Quant Ranking